Study Finds Ozempic and Wegovy Linked to Condition Causing Blindness
Even a blind hog finds the occasional Twinkie
In Galatians 5:19-20, Paul lists off the works of the flesh, acts which will not inherit the kingdom of God.
One of the acts is sorcery.
The Greek word he used was pharmakeia.
There is a kind of magical thinking behind thinking you can take pills and solve your problems. That’s not where health comes from—whether you mean spiritual wellbeing or physical fitness.*
Most pharmaceuticals are scams where you trade out one huge problem (like obesity) for the loss of some key trait like, oh, eyesight.
People who have been prescribed a weight-loss injection could be at a higher risk of developing an eye condition which can lead to blindness, a study has found.
The study found that people with diabetes who were prescribed semaglutide, most commonly known under the brand names Wegovy and Ozempic, were more than four times more likely to be diagnosed with an eye condition known as non-arteritic anterior ischemic optic neuropathy (naion).
Naion is a disorder in which the arteries which supply blood to the optic nerve in the eye become blocked. The condition can lead to loss of eyesight due to the optic nerve being deprived of oxygen and subsequently damaged. There is no known treatment for the condition, which affects 10 out of 100,000 people in the general population.
The research, published in the journal JAMA Ophthalmology and conducted by researchers at Harvard University, looked at data from 16,827 patients at the Mass Eye and Ear Harvard teaching hospital, who received treatment over a six-year period.
Of the patients included within the study, 710 had type 2 diabetes, with 194 of those patients having been prescribed semaglutide.
Included in the study were 975 patients who were overweight or living with obesity, with 361 of these having been prescribed semaglutide.
Of the people included in the study with type 2 diabetes, 17 naion events occurred in patients who were prescribed semaglutide, compared with six who were on other diabetes drugs.
Over three years, 8.9% of these people on semaglutide had naion compared with 1.8% on the other drugs, the researchers found.
The study also found that people who were overweight or living with obesity who were prescribed semaglutide were more than seven times more likely to develop the condition than those on other types of weight-loss medicine.
If you are fat and want to lose weight, fix your diet and go to the gym. In that order.
Do not take these pills that jerk with your metabolism and do unknown things to your brain and nervous system. This is deranged!
What you eat (whole foods that you cooked yourself) is more important for health than exercise, but exercising is also hugely beneficial.
You can’t solve almost any health problems with these pharmaceuticals. (See also the safe-but-deadly vaccines.)